Market Access/ News/ News Third FDA rejection for Verrica’s molluscum contagiosum drug Phil Taylor dermatology, drug devices, infectious disease, molluscum contagiosum, Verrica Pharmaceuticals, VP-102 0 Comment Shares in US biotech Verrica Pharma lost half their value today after the FDA declined to approve its Share X Third FDA rejection for Verrica’s molluscum contagiosum drug https://pharmaphorum.com/news/third-fda-rejection-for-verricas-molluscum-contagiosum-drug/